- Home
- TIL vs INVE Comparison
TIL vs INVE Comparison
Compare TIL & INVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TIL | INVE |
|---|---|---|
| Founded | 2018 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.7M | 74.8M |
| IPO Year | 2021 | 1997 |
Fundamental Metrics
Financial Performance| Metric | TIL | INVE |
|---|---|---|
| Price | $9.04 | $3.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $125.00 | $5.50 |
| AVG Volume (30 Days) | ★ 41.1K | 32.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 52.54 | ★ 1182.76 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $60,219,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $11.82 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.21 |
| 52 Week Low | $5.67 | $2.86 |
| 52 Week High | $42.75 | $4.07 |
Technical Indicators
Market Signals| Indicator | TIL | INVE |
|---|---|---|
| Relative Strength Index (RSI) | 58.14 | 58.59 |
| Support Level | $8.14 | $3.40 |
| Resistance Level | $9.81 | $3.49 |
| Average True Range (ATR) | 0.64 | 0.17 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 58.68 | 56.49 |
Price Performance
Historical ComparisonAbout TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About INVE Identiv Inc.
Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has one reportable segment: the IoT Business segment. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific.